Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L) (C-Term) Peptide
Quick Overview for Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L) (C-Term) Peptide (ABIN8095676)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- BRMS1L Peptide - C-terminal region
-
Sequence
- GQTICIDKKD ECPTSAVITT INHDEVWFKR PDGSKSKLYI SQLQKGKYSI
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-BRMS1L Antibody (ARP60403_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- BRMS1L (Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L))
-
Background
-
Background Information: The protein encoded by this gene shows sequence similarity to the human breast carcinoma metastasis suppressor (BRMS1) protein and the mammalian Sds3 (suppressor of defective silencing 3) proteins. This protein is a component of the mSin3a family of histone deacetylase complexes (HDAC).
Alternative Symbols: BRMS1, MGC11296
-
Molecular Weight
- 37kDa
-
Gene ID
- 84312
-
NCBI Accession
- NP_115728
-
UniProt
- Q5PSV4
Target
-